Market Snapshot

BSE Sensex: 85267.66 0.53%
BSE 500: 37228.82 0.72%
BSE 200: 11752.7 0.68%
BSE 100: 27246.8 0.61%
BSE MidCap: 46477.51 1.14%
BSE SmallCap: 50890.67 0.65%
BSE BANKEX: 66662.68 0.30%
BSE IT: 37004.68 0.45%
Nifty 50: 26046.95 0.57%
Nifty 500: 23726.2 0.74%
Nifty 200: 14469.3 0.72%
Nifty 100: 26565.1 0.62%
Nifty Midcap 100: 60283.3 1.18%
Nifty Small 100: 17389.95 0.94%
Nifty IT: 38274.75 0.47%
Nifty PSU Bank: 8247.8 0.15%

News:

United Drilling Tools secures ...
Biocon?s arm inks pact to comm...
GPT Infraprojects secures Rs 5...
KEC International bags Rs 1,15...
Astra Microwave Products bags ...

Senores Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

12 Dec 2025 | 04:14 PM

786.10

22.45 (2.94%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

0%

Return (1Y)

Underperformed Nifty 50 by 6.1%
More Volatile

3.16%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.4%
Consistent Performer

8/12

Months

beaten Nifty 50
AxisDirect View

No View

52 Week High-Low

832

435

News & Announcements

Senores Pharmaceuticals consolidated net profit rises 152.18% in the September 2025 quarter
39 days ago

Senores Pharmaceuticals consolidated net profit rises 152.18% in the September 2025 quarter

06 - Nov - 2025 12:00 | 39 days ago

Net profit of Senores Pharmaceuticals rose 152.18% to Rs 32.38 crore in the quarter ended September 2025 as against Rs 12.84 crore during the previous quarter ended September 2024. Sales rose 56.08% to Rs 153.36 crore in the quarter ended September 2025 as against Rs 98.26 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 153.36 98.26 56

OPM % 32.28 23.68 -

PBDT 48.73 19.86 145

PBT 40.64 15.97 154

NP 32.38 12.84 152

Powered by Capital Market - Live News
Senores Pharmaceuticals to convene board meeting
46 days ago

Senores Pharmaceuticals to convene board meeting

30 - Oct - 2025 12:00 | 46 days ago

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 November 2025.
Powered by Capital Market - Live News
Stock Alert: Senores Pharma, Ramky Infra, Thomas Cook, Sai Life Sciences
87 days ago

Stock Alert: Senores Pharma, Ramky Infra, Thomas Cook, Sai Life Sciences

19 - Sep - 2025 12:00 | 87 days ago

Securities in F&O Ban:
RBL Bank, Angel One and HFCL shares are banned from F&O trading on 19 September 2025.
Stocks to Watch:
Senores Pharmaceuticals announced that it has further made an investment of $1,999,968 (120,480 equity shares at $16.60 each on a rights basis) in its arm, Senores Pharmaceuticals Inc., via a rights issue.
Ramky Infrastructure announced that the Hyderabad Metropolitan Water Supply and Sewerage Board has executed a concessionaire agreement with the company's arm, Mallannasagar Water Supply. The total value of the project is Rs 2,085 crore.
Sterling Holiday Resorts, a subsidiary of Thomas Cook, has launched the 'Sterling Hibis Vellore' resort.
Sai Life Sciences announced that it has successfully opened a dedicated facility for veterinary API production in Bidar, India. With this expansion, the company aims to provide efficient and scalable manufacturing solutions to leading global animal health companies.
Electronics Mart India announced that the company has commenced operations of a new multi-brand store under the brand name Bajaj Electronics in Andhra Pradesh.
PNC Infratech announced that it has received a provisional completion certificate for the project ?Four Laning of LH 5308 from Mathura Bypass?.
Texmaco Rail & Engineering announced that it has received an order worth Rs 87 crore from Ultratech Cement for BCFC wagons along with a brake van.
John Cockerill India announced that it has received a contract from Tata Steel for the Push-Pull Pickling Line and Acid Regeneration Plant.
Century Plyboards (India) announced that it has re-appointed Sajjan Bhajanka as chairman and managing director for five more years, effective 1 April 2026.
Metropolis Healthcare has acquired Ambika Pathology under a business transfer agreement. Post-transfer, the operations of Ambika Pathology are now being carried out under the company.
Indian Hotels Company clarified that the report regarding the sale of New York?s Pierre Hotel is misleading and speculative. The company does not own The Pierre in New York.
Powered by Capital Market - Live News
Senores Pharmaceuticals to conduct AGM
109 days ago

Senores Pharmaceuticals to conduct AGM

28 - Aug - 2025 12:00 | 109 days ago

Senores Pharmaceuticals announced that the 8th Annual General Meeting(AGM) of the company will be held on 18 September 2025.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Senores Pharmaceuticals Ltd is trading very close to its All time High
Senores Pharmaceuticals Ltd is trading very close to its 52 Week High
FII shareholding in Senores Pharmaceuticals Ltd has increased by 16.83% since past 3 Months
MF shareholding in Senores Pharmaceuticals Ltd has increased by 17.99% since past 3 Months

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	153.36	98.26	56
OPM %	32.28	23.68	-
PBDT	48.73	19.86	145
PBT	40.64	15.97	154
NP	32.38	12.84	152

General Notifications

My Notifications

Research Notifications

Senores Pharmaceuticals Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

786.10 22.45 (2.94%)

News & Announcements

Price vs Volume

Stock Trivia

Senores Pharmaceuticals Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

786.10

22.45 (2.94%)